Bon Secours Mercy Health is nearing an agreement to acquire a controlling stake in Surgery Partners in a transaction valuing the outpatient surgical care provider at about $6 billion, including debt. The Potential transaction may be announced as soon as Monday, and it would price the short-stay surgery operator at around $20 per share, according to a Sunday report by the Financial Times, citing informed sources.
Bon Secours Mercy Health is in advanced negotiations to acquire a controlling stake in Surgery Partners, putting the company’s valuation at around $20 per share. Private equity firm Bain Capital, which has held a minority stake since 2017, will continue to hold its approximately 40 per cent ownership stake in Surgery Partners following the completion of the take-private transaction, maintaining its significant investment in the company after the deal is finalised.
Also read: ASI makes $3 Billion in Latest Funding Round Series C
Bon Secours has become the latest non-profit healthcare organisation to enter into a major transaction, reflecting a broader trend of large-scale deals among not-for-profit healthcare providers. The acquisition of Surgery Partners would substantially strengthen Bon Secours’ presence in the outpatient healthcare sector and speed up its expansion into ambulatory care services. It has generated substantial returns from its investment in Ensemble Partners, a specialist in healthcare payment software, which it initially invested in back in 2016.
